Toxicity and Bone Marrow Response of Patients with Hairy Cell Leukemia Treated with Biosynthetic (recombinant) Alpha-2-interferon

Overview

Journal Blut

Specialty Hematology

Date 1985 Jan 1

PMID 3967099

Citations 3

Authors

A D Jacobs

F Naiem

R E Champlin

D W Golde

Affiliations

Soon will be listed here.

Citing Articles

Long-lasting remission of hairy cell leukemia after eight weeks' therapy with low-dose alpha-(leucocyte-)interferon.

Duhrsen U, Meusers P, Gries E, Brittinger G Blut. 1985; 51(4):297-8.

PMID: 3850754 DOI: 10.1007/BF00320525.

Primary treatment of hairy cell leukemia: should IFN-therapy replace splenectomy?.

Porzsolt F Blut. 1986; 52(5):265-72.

PMID: 3635415 DOI: 10.1007/BF00320789.

Preclinical safety testing of species-specific proteins produced with recombinant DNA-techniques. An attempt to transfer current experience into future testing strategies.

Teelmann K, Hohbach C, Lehmann H Arch Toxicol. 1986; 59(4):195-200.

PMID: 3548648 DOI: 10.1007/BF00290537.

References

Quesada J, Reuben J, Manning J, Hersh E, Gutterman J . Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med. 1984; 310(1):15-8. DOI: 10.1056/NEJM198401053100104. View